Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP383381.RAAvKrp-pCyoXw5fEkVLQp0MamAy96jLMjFOSlY-eGN4A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP383381.RAAvKrp-pCyoXw5fEkVLQp0MamAy96jLMjFOSlY-eGN4A130_assertion type Assertion NP383381.RAAvKrp-pCyoXw5fEkVLQp0MamAy96jLMjFOSlY-eGN4A130_head.
- NP383381.RAAvKrp-pCyoXw5fEkVLQp0MamAy96jLMjFOSlY-eGN4A130_assertion wasGeneratedBy ECO_0000203 NP383381.RAAvKrp-pCyoXw5fEkVLQp0MamAy96jLMjFOSlY-eGN4A130_provenance.
- NP383381.RAAvKrp-pCyoXw5fEkVLQp0MamAy96jLMjFOSlY-eGN4A130_assertion wasDerivedFrom befree-20140225 NP383381.RAAvKrp-pCyoXw5fEkVLQp0MamAy96jLMjFOSlY-eGN4A130_provenance.
- NP383381.RAAvKrp-pCyoXw5fEkVLQp0MamAy96jLMjFOSlY-eGN4A130_assertion SIO_000772 21107094 NP383381.RAAvKrp-pCyoXw5fEkVLQp0MamAy96jLMjFOSlY-eGN4A130_provenance.
- NP383381.RAAvKrp-pCyoXw5fEkVLQp0MamAy96jLMjFOSlY-eGN4A130_assertion evidence source_evidence_literature NP383381.RAAvKrp-pCyoXw5fEkVLQp0MamAy96jLMjFOSlY-eGN4A130_provenance.
- NP383381.RAAvKrp-pCyoXw5fEkVLQp0MamAy96jLMjFOSlY-eGN4A130_assertion description "[Although Her-2-overexpression in esophageal cancer seems to have no influence on patients' survival, these subtypes of esophageal ACs have to be considered as targets for an anti-Her-2 therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP383381.RAAvKrp-pCyoXw5fEkVLQp0MamAy96jLMjFOSlY-eGN4A130_provenance.